Abstract

A series of new coelenterazine analogs with varying substituents at the C-6 position of the imidazopyrazinone core have been designed and synthesized for the extension of bioluminescence substrates. Some of them display excellent bioluminescence properties compared to DeepBlueC™ or native coelenterazine with both in vitro and in vivo biological evaluations, thus placing these derivatives among the most ideal substrates for Renilla bioluminescence applications.

Highlights

  • Bioluminescence, as a special form of chemiluminescence, is a natural phenomenon that emits cold light resulting from the reaction catalyzed by the corresponding luciferase in biological systems

  • Some coelenterazine derivatives including coelenterazine h, coelenterazine 400a (DeepBlueCTM), coelenterazine f, coelenterazine fcp and coelenterazine hcp were firstly reported by the Cormier lab during the period of 1973–1979.28,29 Besides, several characteristic coelenterazine analogues have been designed and synthesized in recent years

  • Promega Corporation developed a new coelenterazine derivative named furimazine that contains a furan group at the C-2 position in 2012.30 Furimazine is a potent substrate for NanoLuc, an Oplophorus luciferase variant engineered by Promega Corporation

Read more

Summary

Introduction

Bioluminescence, as a special form of chemiluminescence, is a natural phenomenon that emits cold light resulting from the reaction catalyzed by the corresponding luciferase in biological systems. It is of great significance that the compound B2 is superior over coelenterazine: it demonstrated higher bioluminescence intensity, better kinetic characteristics, brighter and longer emission with Rluc in cellulo and in vivo.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.